Lv32
260 积分 2025-01-23 加入
Targeting Solid Tumors Using CD3 Bispecific Antibodies
6天前
已完结
Glecirasib with or without cetuximab in previously treatedlocally advanced or metastatic colorectal cancer with KRASs12cmutation (JAB-21822-1002 andJAB-21822-1007):two open-label, non-randomised phase 1/2 trials
1个月前
已完结
Glecirasib plus sitneprotafib in patients with KRASG12Cmutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
1个月前
已完结
Prognostic impact of pleural lavage cytology in EGFR-stratified resected non-small cell lung cancer
1个月前
已完结
Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease
1个月前
已关闭
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study
1个月前
已完结
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11 -Mutant Tumors to Anti–PD-1 Immunotherapy
1个月前
已完结
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
1个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
